A8X775 AF NFT

Mitogen-activated protein kinase kinase kinase dlk-1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihbjl3ujyu3ul26zadhpmz3l7qgr5hhe3fmxeggdlgoawsn7nmwwi/metadata.json
IPFS of structure file: 
bafybeiacxdieqei7ow4sfsaihpsddeyi3udxdll257fahbn5ggd75rlriy/AF-A8X775-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x1549cA1d9C2Be61a42eFaCA21D299D03Be72296F
First NFT owner address (bech32): 
genesis1z4yu58vu90np5sh04j3p62vaqwl8y2t025u7pz
Current NFT ID #98923 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
98923
Accession (UniProt):
A8X775
Name::
Mitogen-activated protein kinase kinase kinase dlk-1
Experimental Method:
Predicted structure
Sequence source:
Caenorhabditis briggsae

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A8X775 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A8X775|DLK1_CAEBR Mitogen-activated protein kinase kinase kinase dlk-1 OS=Caenorhabditis briggsae OX=6238 GN=dlk-1 PE=3 SV=1 MMAAAGNASKPSLNNFYAEGLGHLREGLFSCFRPVLGYFGGKPTQEIEKTEDEGWEIPFDAISNLEWLGSGSQGAVFHGQYENRTVAVKKVNQLKETEIKHLRHLRHKNIIEFLGVCSKSPCYCIVMEYCPKGQLCTVLRQKNLITRQMFSDWVKEIADGMHYLHQNKVIHRDLKSPNILISAEDSIKICDFGTSHLQKKNDSTMMSFCGTVSWMAPEMIKKEPCNEKVDVYSFGVVLWEMLTRETPYANIAQMAIIFGVGTNILNLPMPEEAPRGLVLLIKQCLSQKGRNRPSFSHIRQHWEIFKPELFEMTEDEWQVAWDSYREFAKAIQYPSTVTKDHGGPKSAFAMEEEMQRKRHEQLNHIKDIRHMYEAKLKRTNKMYDKLQGCFTELKLKEHELAEWERNLAEREQMHVYNSPRSMSAAPRFQLRGNCYPNEAYEEMSSDEDGQCPPCRGSPYRNSNMSTSSGAQSSPFSRQSSCRSSAGQQTRRSEGANAQKISRNDLLRHSSSYWETIGNRGSPARGSGFSQDSGVWSAGVSSMAINGGVQGGVPVTYAQTIYRNGEGRWSDGRIASRRRVSSSANKNLPPVFFTRDSPSRVPHGVVNHSAPRSSSKLNRSSYPSRNAPHQLEDGCCCNHGRVPRAKSVAVSMATRGRSPTPYDNDASDAAENPDIHYELQIPETTSYDEALKSIGETDDVEMDAANGVNPIYSSPITTYNNPCHVNYENVTEENANDIDLTSSMDSRRSRADDADVESSEDEGNGNNILNTSMESEELRYRIDTSQSTMMSSLERSLEIGATRSDGLSDNERRVQAVKHSIKTHRRTSSNPQAIIHQRIEEYSSSATEDSDDAGAVRI